Hong Kong stocks' innovative drug sector continued to fall, with BeiGene falling more than 10%

2025-05-12 14:38:39

The Hong Kong stock market's innovative drug sector continued to decline, with BeiGene and Ascletis Pharmaceuticals-B both falling by more than 10%, Innovent Biologics falling by more than 7%, and Zhaoyan Pharmaceutical and CSPC Pharmaceutical Group leading the decline.

BeiGene

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Hong Kong stocks opened: Hang Seng Index opened 0.14% higher, Hang Seng Technology Index opened 0.13% higher
                            2025-06-06

                                    A U.S. appeals court rejected Apple's (AAPL.O) request to suspend an order on App Store reforms in its lawsuit against Epic Games, court documents showed.
                            2025-06-05

                                    Cainiao continues to deploy logistics + AI and joins hands with China Eastern Airlines to build the world's first smart hangar
                            2025-06-06

                                    South Korea's exports fell 1.3% in May from a year earlier
                            2025-06-01

                                    Project establishment and formulation of safety requirements for combined driving assistance systems for intelligent connected vehicles
                            2025-06-04